Evidence map›Paper›PMID 42208123›Full record

ArticleJMIR medical informatics2026

Advancing Alzheimer Disease Prediction With Large Language Model-Based Linguistic Feature Analysis: Development and Validation Study.

Ming-Hsia Hsu, San-Yih Hwang, Yi-Hang Tsai, Yun-Chi Chang, Chih-Kuang Liang, Chiung-Yun Chang

Abstract readValidation Study
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ming-Hsia HsuDepartment of Information Management, National Sun Yat-sen University, No. 70, Lienhai Rd, Kaohsiung, 804201, Taiwan, +886-7-5252000 ext 4723.ORCID 0009-0007-3793-3153
San-Yih HwangDepartment of Information Management, National Sun Yat-sen University, No. 70, Lienhai Rd, Kaohsiung, 804201, Taiwan, +886-7-5252000 ext 4723.ORCID 0009-0006-4044-648X
Yi-Hang TsaiDepartment of Information Management, National Sun Yat-sen University, No. 70, Lienhai Rd, Kaohsiung, 804201, Taiwan, +886-7-5252000 ext 4723.ORCID 0009-0000-2139-9354
Yun-Chi ChangDepartment of Information Management, National Sun Yat-sen University, No. 70, Lienhai Rd, Kaohsiung, 804201, Taiwan, +886-7-5252000 ext 4723.ORCID 0009-0005-8936-7419
Chih-Kuang LiangDivision of Neurology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.ORCID 0000-0003-1604-1600
Chiung-Yun ChangDepartment of Information Systems, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan.ORCID 0009-0001-5767-9056

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alzheimer disease (AD) is a progressive neurodegenerative disorder with rapidly growing global prevalence. Early detection is critical for timely intervention; yet, conventional diagnostic methods remain costly and invasive. Speech-based assessment has emerged as a noninvasive alternative, as AD characteristically impairs linguistic abilities including fluency, coherence, and informational content. Recent advances in large language models (LLMs) offer new opportunities to extract structured linguistic features from transcribed speech for automated AD classification. However, existing LLM-based approaches often lack transparency and clinical interpretability, limiting their adoption in clinical workflows. Objective: This study aims to investigate the influence of linguistic features extracted from transcribed speech, as analyzed by LLMs, on the accuracy and interpretability of AD prediction. Methods: We propose a framework that leverages LLMs to analyze linguistic features extracted from transcribed speech for AD classification. Our approach focuses on 4 key aspects, including readability, fluency, richness of detail, and keyword relevance. To enhance classification accuracy, the framework integrates transcript embeddings with feature explanation embeddings, forming a comprehensive linguistic representation. We conducted extensive ablation studies to evaluate the contributions of individual features and benchmarked our framework against existing LLM-driven methodologies through pairwise explainability evaluations. Output stability was assessed across 3 independent pipeline runs. A fully local configuration (Llama 3 8B + nomic-embed-text) was tested to evaluate privacy-preserving deployment feasibility. Explainability was assessed via LLM-based pairwise comparison (Gemini-3.1-flash-lite) against the method of Bang et al across 54 correctly classified cases and by blinded evaluation from 2 neurologists. Results: The proposed framework achieved a mean precision of 91.52%, a sensitivity of 91.08%, a specificity of 96.29%, and F1-score of 91.05% across 3 independent runs on the ADReSSo 2021 dataset, outperforming existing LLM-based approaches. A fully-local configuration (Llama 3 8B+nomic-embed-text, requiring no cloud application programming interface access) achieved an F1-score of 81.58%, demonstrating framework transferability to privacy-preserving deployment environments. Keyword relevance was the most influential feature (F1-score drop of 13.22 pp when removed). Explainability evaluations showed our method was preferred in 49 out of 54 cases via Gemini-3.1-flash-lite, with human experts preferring our method in 89 of 108 blinded assessments. Conclusions: These findings highlight that a structured linguistic feature analysis using LLMs provides a robust and interpretable framework for preliminary AD detection. Our approach offers a scalable and accessible solution that bridges artificial intelligence-driven text analysis with clinical applications, supporting early detection of cognitive decline through noninvasive assessment methods.

Indexed as

Alzheimer DiseaseLinguisticsHumansLarge Language ModelsPrediction Algorithmsalzheimer diseaseearly detectionlarge language modelslinguistic featuresprompt engineering

Identifiers

PMID42208123
PMCPMC13218719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.